Bio-Combination 13 (Rxhomeo Private Limited d.b.a. Rxhomeo, Inc)
Welcome to the PulseAid listing for the Bio-Combination 13 drug offered from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
| NON-PROPRIETARY NAME: | CALCAREA PHOSPHORICA, KALI MURIATICUM, KALI PHOSPHORICUM, KALI SULPHURICUM, NATRUM MURIATICUM |
| SUBSTANCE NAME: | TRIBASIC CALCIUM PHOSPHATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; SODIUM CHLORIDE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2016-03-26 |
| END MARKETING DATE: | 0000-00-00 |
Bio-Combination 13 HUMAN OTC DRUG Details:
| Item Description | Bio-Combination 13 from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
| LABELER NAME: | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12; 12; 12; 12; 12([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1) |
| START MARKETING DATE: | 2016-03-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 15631-2368_1a5fc90b-cde2-4ec1-bf58-68b29d7a8cb7 |
| PRODUCT NDC: | 15631-2368 |
| APPLICATION NUMBER: | |
Other TRIBASIC CALCIUM PHOSPHATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; SODIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:
